Ayr Wellness: Doing Even Better
Ayr Wellness reported another strong quarter with Q2 revenues now topping $90 million. The MSO has now updated '22 guidance to revenues of $800 million and adjusted EBITDA of $300 million. The stock is exceptionally cheap at only 6.5x '22 adjusted EBITDA targets. This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More » Most MSO (multi-state operator) stocks continue to struggle while the businesses are booming. Ayr Wellness ( OTCQX:AYRWF ) is no exception with sales surging 56% sequentially to top $90 million for the first time. My investment thesis remains very Bullish on the MSO trading at a small fraction of current growth rates. Read the full article on Seeking Alpha. Disclosure: No position mentioned. Please review the disclaimer page for more details. Update - August 25 A 5% buyback for a MSO is impressive, but the market will probably fear more stock sales in the future....